93 Results (Page 1 of 8)
South Korea Markets Research Reports
South Korea Diabetes Devices Market Analysis
The South Korea Diabetes Devices Market is expected to witness growth from $332 Mn in 2022 to $624 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The South Korean elderly population is predicted to raise the number of diabetes diagnoses, which will increase demand for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Dongmun, Sejung Medical Industry, Medyssey, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
South Korea Cardiac Surgery Instruments Market Analysis
The South Korea Cardiac Surgery Instruments Market is expected to witness growth from $30 Mn in 2022 to $54 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. In South Korea, the frequency of coronary artery disease is rising as a result of urbanization, lifestyle shifts, and elderly people. The increase in patients who need surgical procedures is expected to increase the demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Nanoomtech, Kolon Life Science, L&K Biomed, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
South Korea Artificial Intelligence (AI) in Healthcare Market Analysis
The South Korea Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.1 Bn in 2022 to $2.11 Bn by 2030, registering a CAGR of 46.22% during the forecast period of 2022 - 2030. The market will be driven by government support for the development of AI in healthcare, the country's advanced IT infrastructure and a high level of digital literacy among its citizens. The market is segmented by healthcare components & by healthcare applications. Some of the major players include Samsung Electronics, LG CNS & VUNO.
South Korea Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Liver Disease Therapeutics market will reach a value of $567 Mn from $337 Mn in 2022, growing at a CAGR of 6.7% during 2022-2030. Liver Disease Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Bukwang Pharm, Dong-A ST, and LISCure Biosciences. The Liver Disease Therapeutics market in South Korea is segmented into different types of disease and different therapy types. Some of the major factors affecting the South Korea Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
South Korea Healthcare Insurance Market Analysis
The South Korean healthcare insurance market is projected to grow from $29.61 Bn in 2022 to $57.28 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be rising healthcare costs, increasing disposable income, government support and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Samsung Life Insurance, Hanwha Life Insurance, Kyobo Life Insurance, KB Insurance and Cigna.
South Korea Biomaterials in Healthcare Market Analysis
The South Korea Biomaterials Healthcare Market is expected to witness growth from $2.28 Bn in 2022 to $6.60 Bn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. With a large percentage of elderly residents, South Korea has one of the world's fastest aging populations. As a result, there is a rising need for biomaterials and medical equipment. The market is segmented by type and by application. Some key players in this market include: Kolon Life Science, Sewon Cellontech, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
South Korea Anti Aging Therapeutics Market Analysis
South Korea anti-aging therapeutics market is projected to grow from $9 Mn in 2022 to $32 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. Presence of advanced technologies and increases research and development initiatives in South Korea is responsible for the expansion of the market. The South Korea anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading companies in the market include Hanmi Pharmaceuticals, SK Bioscience, and Merz Pharma.
South Korea 3D Printing Medical Devices Market Analysis
South Korea 3D Printing Medical Device Market is expected to witness growth from $43 Mn in 2022 to $156 Mn in 2030 with a CAGR of 17.30% for the forecasted year 2022-2030. Numerous international patients looking for high-quality medical care at reasonable costs are choosing South Korea as a popular medical tourism location. The chance to grow their clients and boost sales of 3D printed medical devices is presented to manufacturers. The market is segmented by application, by technology and by end user. Some key players in this market include: AON3D, GE Healthcare, Stryker, Medtronic, MediKors and Philips Healthcare.
South Korea Oncology Clinical Trials Market Analysis
South Korea's oncology clinical trials market is projected to grow from $184.8 Mn in 2022 to $305.9 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the country's well-established infrastructure, advanced medical facilities, and streamlined regulatory processes. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc., Roche Holding AG & SK Biopharmaceuticals.
South Korea ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
South Korea Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $432 Mn in 2022 to $830 Mn in 2030 with a CAGR of 8.5% for the year 2022-30. The increasing awareness about ADHD in South Korea and rising R&D efforts taken by the pharma companies are the driving factors for the growth of the market. The South Korea ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market include Hanmi Pharma, Daewoong Pharma, and Eli Lilly.
South Korea Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Liver Cancer Therapeutics market will reach a value of $ 167.6 Mn from $42.81 Mn in 2022, growing at a CAGR of 18.6% during 2022-2030. Liver Cancer Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Green Cross Cell Corporation, Handok Pharmaceuticals and Yuhan Corporation. The Liver Cancer Therapeutics market in South Korea is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Korea Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
South Korea Connected Healthcare Market Analysis
The South Korean connected healthcare market is projected to grow from $969.62 Mn in 2022 to $7622.15 Mn by 2030, registering a CAGR of 29.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing geriatric population, high-tech culture, government support and the COVID-19 pandemic. The market is segmented by type, function and by application. Some of the major players include Samsung, SK Telecom, Hanwha Group, Oracle, Philips Healthcare and GE Healthcare.
South Korea Neurology Clinical Trials Market Analysis
The South Korea Neurology Clinical Trials market is projected to grow from $76.4 Mn in 2022 to $126.5 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the supportive regulatory environment and increasing interest from pharmaceutical companies investing in neurology clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Hoffmann-La Roche, Biogen & Chong Kun Dang Pharmaceutical.
South Korea Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the South Korean infectious disease therapeutics market will reach a value of $2.66 Bn from $1.75 Bn in 2022, growing at a CAGR of 5.4% during 2022-2030. Infectious Disease Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Green Cross Corporation, SK Bioscience and GC Pharma. The Infectious Disease Therapeutics market in South Korea is segmented into different therapeutic areas and different diseases type. The major factors affecting the South Korean infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of South Korea.
South Korea Artificial Intelligence (AI) in Diagnostics Market Analysis
The South Korea Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.01 Bn in 2022 to $0.17 Bn by 2030, registering a CAGR of 36% during the forecast period of 2022 - 2030. The market will be driven by collaborations among businesses, academia, and healthcare providers and a rise in demand for precise diagnostics. The market is segmented by component & by diagnosis. Some of the major players include Lunit, IBM Watson Health & Siemens Healthineers.
South Korea Palliative Care Market Analysis
The South Korea Palliative care market is projected to grow from $191.12 Mn in 2022 to $380.82 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022 - 2030. The main factors driving the growth would be growing awareness, government support and the ageing population. The market is segmented by service type and by the end user. Some of the major players include Seoul National University Hospital, Calvary Clinic, Bobath Memorial Hospital, Chunchon St. Colomban Clinic, Daegu Fatimah Hospital and Daejeon St. Mary’s Hospital.
South Korea 3D Imaging Market Analysis
The South Korea 3D Imaging market is projected to grow from $0.44 Bn in 2022 to $1.61 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022 - 2030. The market will be driven by the implementation of new 3D imaging technology, applications, and support from the government sector. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Samsung Medison.
South Korea Neurology Devices Market Analysis
South Korea Neurology Device Market size is at around $184.41 Mn in 2022 and is projected to reach $362.07 Mn in 2030, exhibiting a CAGR of 8.8% during the forecast period. With the current rates of prevalence of neurological diseases like stroke, Parkinson’s disease, Multiple Sclerosis, and Epilepsy the demand for neurology devices has also surged. Currently, international players like Boston Scientific, Medtronic, and Stryker dominate the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
South Korea Cancer Pain Management Market Analysis
The South Korea Cancer Pain Management market is projected to grow from $95.27 Mn in 2022 to $155.31 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-2030. The main factors driving the growth would be technological and pharmaceutical advancements, increasing awareness, and government support. The market is segmented by drug type and by disease. Some of the major players include Hanmi Pharmaceutical (KOR), Pfizer, Teva Pharmaceuticals, Abbott, and Sanofi.
South Korea Dermatology Drugs Market Analysis
By 2030, it is anticipated that the South Korea Dermatology drugs market will reach a value of $606 Mn from $248 Mn in 2022, growing at a CAGR of 11.8% during 2022-2030. The market is primarily dominated by local players such as CosmoFarma Korea, JW Pharmaceuticals, and Samjeong Pharma. The market is driven by locally produced drugs, awareness about dermatological health, and government regulations. The dermatology drug market in South Korea is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
South Korea Nutritional Supplements Market Analysis
By 2030, it is anticipated that the South Korea Nutrition and Supplements market will reach a value of $11.52 Bn from $5.57 Bn in 2022, growing at a CAGR of 9.5% during 2022-2030. The market is primarily dominated by local players such as Dong-A Pharmaceutical, Kolmar Korea, and Kolmar Korea. The market for nutrition and supplements in South Korea is primarily driven by government initiatives, increasing consumer awareness of health and lifestyle, and strict government regulations. The South Korea nutrition and supplements market in South Korea is segmented by Type, Product, application, and Distribution Channel.
South Korea Home Healthcare Market Analysis
The South Korea home healthcare market was valued at $5.29 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $10.50 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, The increased prevalence of chronic ailments. The market is segmented by equipment outlook and by services. Some key players in this market are BAYDA Home Healthcare, Samsung Medical Centre, Seoul National University Hospital, Asan Medical Center, and National Health Insurance Service (NHIS).
South Korea HIV Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea HIV therapeutics market will reach a value of $268.9 Mn from $201.1 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. The market is primarily dominated by local players such as Dong-A ST, Hanmi Pharmaceuticals, and Celltrion. The market for HIV/AIDS treatment in South Korea is primarily driven by government funding and initiatives, social issues like stigma and discrimination, and diagnostic tools. The HIV therapeutics market in South Korea is segmented by type, product, geography, end user, and distribution channel.
South Korea Electronic Health Records Market Analysis
The South Korea Electronic Health Record (EHR) market size was valued at $413 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5% from 2022 to 2030 and will reach $611 Mn in 2030. South Korea EHR market growth can be attributed to the growing need for better patient care and safety. The market is segmented by product, application, and end user. The key market players are Allscripts, Cerner, Epic Systems, and others.
South Korea Bioinformatics Market Analysis
The South Korea Bioinformatics market is projected to grow from $224.29 Mn in 2022 to $803.88 Mn by 2030, registering a CAGR of 17.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing healthcare industry, technological advancements, growing research and development activities, and expansion of the biotechnology industry. The market is segmented by technology and by application. Some of the major players include Bioneer Corporation (KOR), Macrogen Inc. (KOR), DNALink (KOR), LabGenomics (KOR), QIAGEN, Agilent Technologies, IBM Life Sciences, and ThermoFisher Scientific.